7月1日A股投資避雷針︱退市龍宇:7月3日終止上市暨摘牌;何氏眼科:先進製造基金擬減持不超2%股份
飛龍股份控股股東擬減持不超563.25萬股;立華股份實控人程立力及其一致行動人擬合計減持不超3.00%股份;王子新材實控人王進軍完成減持2.54%股份;赫美集團表示元程序基金擬減持不超3%股份;道氏技術實控人榮繼華擬減持不超2%股份;何氏眼科表示先進製造基金擬減持不超2%股份;海天瑞聲股東賀琳及其一致行動人中毅安擬減持合計不超過2.9463%股份;退市龍宇7月3日終止上市暨摘牌際華集團現有產品體系未涉及腦機接口相關領域

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.